肠道菌群和结直肠癌发生发展及治疗的研究进展

Advances in the relationship between gut microbiota and colorectal cancerdevelopment and treatment

  • 摘要: 结直肠癌作为全球发病和死亡居首位的消化系统恶性肿瘤,其与肠道菌群的关系越来越受到关注。肠道菌群可以与宿主细胞相互作用,调节包括新陈代谢和免疫反应在内的多种生理过程。近年来,随着研究不断深入,已经揭示了宿主与肠道菌群之间的相互作用在结直肠癌的起源和进展中发挥重要作用。本综述旨在通过描述结直肠癌相关的肠道微生物群以及瘤内微生物群,讨论肠道菌群参与结直肠癌的发生、侵袭、转移过程的具体机制,及其对结直肠癌治疗反应和预后的影响,为深入了解肠道菌群与结直肠癌的关系提供参考,并为开发菌群干预结直肠癌提供治疗思路。

     

    Abstract: Colorectal cancer (CRC), the most common malignant tumor of the digestive system with the highest morbidity and mortality worldwide, has received increasing attention for its relationship with the gut microbiota. The gut microbiota interacts with the host cells to regulate various physiological processes, including metabolism and immune responses. Recently, increasing research has revealed that the interaction between the host and gut microbiota plays a significant role in the origin and progression of CRC. In this review, we discuss the specific mechanisms of the gut microbiota involvement in the carcinogenesis, invasion, and metastasis of CRC, as well as its impact on the therapeutic response and prognosis, by describing the gut and intratumoral microbiota associated with CRC. This information serves as a reference for understanding the relationship between gut microbiota and CRC, and provides therapeutic ideas for the development of microbiota-based interventions for CRC treatment.

     

/

返回文章
返回